Howard S. Oster

Tel Aviv Sourasky Medical Center — Israel

Medicine · Health Sciences

18h-index1.5kcitations112works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(32), Erythropoietin and Anemia Treatment(22), Hematological disorders and diagnostics(16), Myeloproliferative Neoplasms: Diagnosis and Treatment(12), Blood groups and transfusion(9)

Publications112 total

Diabetes mellitus and diabetes-related complications are common in patients with myelodysplastic syndromes but Hemoglobin A1C is an inadequate marker
Haematologica·2026Open Access
Rethinking the effectiveness of hypomethylating agents in myelodysplastic syndromes: the 50%-2-year wall
Haematologica·2026Open Access
Non-invasive MDS diagnostic algorithm can also identify pre-MDS and distinguishes normal controls from MDS/pre-MDS patients without bone marrow examination
Blood·2025Open Access
ANKRD26-related thrombocytopenia: Hematologic malignancy characteristics, clinical outcomes, and precursor states
Blood·2025Open Access
PROGNOSIS - PROGNOSTIC FACTORS OF OUTCOME AND RISK ASSESSMENT
Leukemia Research·2025
RAPID FIRE SESSION 02
Leukemia Research·2025Open Access
PROGNOSIS - PROGNOSTIC FACTORS OF OUTCOME AND RISK ASSESSMENT
Leukemia Research·2025Open Access
Next‐generation morphology, a novel multilayer morphometric digital analysis, reveals both the basic topology and new trends of myelodysplasia of peripheral blood specimens
British Journal of Haematology·2025Open Access
Neutropenia (even mild) and anemia are poor prognostic factors in myelodysplastic syndromes
Frontiers in Medicine·2025· 1 citedOpen Access
Can we identify individuals at risk to develop multiple myeloma? A machine learning‐based predictive model
British Journal of Haematology·2025· 2 citedOpen Access
Do we Need to Perform Bone Marrow Examination in all Subjects Suspected of <scp>MDS</scp>? Evaluation and Validation of Non‐Invasive (Web‐Based) Diagnostic Algorithm
European Journal Of Haematology·2025
Diagnosis of myelodysplastic syndromes: the classic and the novel
Haematologica·2024· 4 citedOpen Access
How we diagnose Myelodysplastic syndromes
Frontiers in Oncology·2024· 1 citedOpen Access
Validation of a novel algorithm with a high specificity in ruling out <scp>MDS</scp>
International Journal of Laboratory Hematology·2024· 4 citedOpen Access
Do We Still Need to Perform Bone Marrow Examination in All Subjects Suspected of MDS? Evaluation and Validation of Non-Invasive (Web-Based) Algorithm
Blood·2023
MDS-Related Anemia Is Associated with Impaired Quality of Life but Improvement Is Not Always Achieved by Increased Hemoglobin Level
Journal of Clinical Medicine·2023· 8 citedOpen Access
Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation
Mediterranean Journal of Hematology and Infectious Diseases·2023· 2 citedOpen Access
Lymphoid aggregates in the bone marrow biopsies of patients with myelodysplastic syndromes – A potential prognostic marker?
Frontiers in Oncology·2023· 2 citedOpen Access
Validation of a Novel Algorithm with a High Specificity in Ruling out MDS
Blood·2022
Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry: A Report on 197 Cases
Blood·2022
page 1 of 6Next →

Frequent Co-authors

Moshe Mittelman(32), Drorit Neumann(14), Yoram Rudy(7), Michael A. Hoffman(7), Sara Prutchi‐Sagiv(6), Odelia Katz(5), Kalman Filanovsky(5), Nathalie Ben‐Califa(4), Ilya Kirgner(4), Pia Raanani(4), B Taccardi(3), Robert L. Lux(3), Elizabeth Naparstek(3), Naamit Deshet‐Unger(3), Albert Kolomansky(3), Sahar Hiram‐Bab(3), Tamar Liron(3), Yankel Gabet(3), Albert Kolomansky(3), Uri Greenbaum(3)